ABIOMED Inc
LSE:0H7S
Relative Value
There is not enough data to reliably calculate the relative value of 0H7S.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
0H7S Competitors Multiples
ABIOMED Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
ABIOMED Inc
LSE:0H7S
|
17.2B USD | 16 | 64.5 | 58.2 | 64.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.3B USD | 4.4 | 30.1 | 17.1 | 23.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176B USD | 17.4 | 61.5 | 46.7 | 57.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.3B USD | 5.5 | 42.6 | 21.6 | 26.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
128.3B USD | 3.7 | 27 | 15.1 | 21.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.2B USD | 5.4 | 37.7 | 22.4 | 30.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.3B EUR | 1.9 | 21.3 | 11.8 | 16.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.8B USD | 2.4 | 30.9 | 11.7 | 19.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.4B USD | 12 | 48.8 | 34.9 | 38.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD | 7.8 | 33.4 | 23.8 | 26 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.7B USD | 7 | 25.5 | 18 | 20.1 |